Personalized Brain Stimulation Shows Promise for Some Autistic Adults in Early Trial

Targeted Brain Stimulation Shows Modest Benefits in Autistic Adults

A form of noninvasive brain stimulation tailored to individual neural patterns showed statistically significant but modest improvements in social communication and repetitive behaviors for some autistic adults in a double-blind, randomized controlled trial involving 78 participants. The study tested accelerated intermittent theta burst stimulation (aTBS) targeting brain networks involved in attention regulation. While not a cure and not yet tested in children, this early-phase research published in Molecular Psychiatry suggests a potential direction for future support strategies. Larger, longer studies are needed to confirm and extend these findings.

Vaccination Research Confirms Established Safety Profile

A study of 2.5 million U.S. children reported by CIDRAP found identical autism rates between children who received the measles-mumps-rubella (MMR) vaccine before age 2 and those who didn't, after accounting for family medical history. This adds to over two decades of consistent evidence disproving any link between vaccination and autism recognition patterns.

Vaccination Research Confirms Established Safety Profile A study of 2.5 million U.S.

Mouse Study Explores Inflammation Mechanisms

UCLA researchers reported that a drug reduced inflammation-related behavioral differences in mice within hours of administration. While scientifically interesting for understanding neurodevelopmental processes, the team emphasized these preclinical findings don't directly translate to human applications. Many mouse studies of autism-related mechanisms fail to show similar effects in people due to the complexity of human neurodevelopment.